Table 4.
Baseline Characteristics of the Subjects
| Bofutsushosan (n=55) | Placebo (n=56) | P valuea | |
|---|---|---|---|
| Age, years | 41.56±8.62 | 39.21±10.12 | .191 |
| Height, cm | 160.5±6.79 | 161.79±7.85 | .357 |
| Body weight, kg | 74.53±10.98 | 76.86±11.7 | .279 |
| WC, cm | 97.63±7.45 | 98.99±7.81 | .380 |
| BMI, kg/m2 | 29.72±6.17 | 29.28±3.11 | .640 |
| Body fat, % | 38.33±4.98 | 39.02±5.39 | .489 |
| Body fat mass, kg | 28.61±6.14 | 29.87±6.83 | .309 |
| RMR, kcal/d | 1396.73±383.55 | 1453.39±335.02 | .414 |
| Fasting BST, mg/dL | 99±9.33 | 98.36±9.04 | .713 |
| T-Chol, mg/dL | 207.69±39.36 | 191.84±40.12 | .038* |
| HDL, mg/dL | 55.27±14.7 | 50.29±11.32 | .047* |
| TG, mg/dL | 127.35±58.62 | 123.02±67.02 | .718 |
| KOQOL | 33.51±7.6 | 34.52±8.56 | .513 |
a
Bofutsushosan vs. placebo by independent t test.
*
P<.05.
WC, waist circumference; BMI, body mass index; RMR, resting metabolic rate; BST, blood sugar test; T-Chol, total cholesterol; HDL, high-density lipoprotein; TG, triglyceride; KOQOL, Korean version of obesity-related quality of life.